Conference agenda

Highlights

• Analysis of China's pharmaceutical exports and internationalisation landscape
• Reflections on pharmaceutical internalisation-export pathways for proprietary branded formulations
• Strategic considerations for peptide drug global expansion
• Collaborative internationalisation—advanced models for Chinese pharmaceutical companies "going global"
• Leveraging Hong Kong and Macau advantages to bring Chinese innovative drugs to the world
• Exploration of API-formulation integration
• Discussion on globalisation pathways for complex

Agenda:

09:30 - 10:00   Sign in
10:00 - 10:10 Opening remark & introduction of speakers
10:10 - 10:30 China's pharmaceutical foreign trade landscape and globalization trends
10:30 - 11:00  Internationalization strategies for formulations: self-export 2.0 under new circumstances
11:00 - 11:30 Partnership models & value restructuring in API internationalization
11:30 - 12:00 Dual-strategy approach: CDMO services in Europe & self-selected product strategies
13:00 - 13:30 Sign-in
13:30 - 14:0 Exploration of the global path for complex formulations
14:00 - 14:30 International opportunities & challenges for Chinese pharma: polypeptide formulation case studies
14:30 - 15:00 Global expansion strategies for biosimilars
15:00 - 15:30 European market entry pathways & strategies for pharmaceuticals
15:30 - 16:00 Emerging market expansion strategies for formulations
15:30 - 16:00 TBD
16:00 - 17:00 Panel discussion: new opportunities and challenges for formulation internationalisation under new circumstances

NEW: This session features AI English translation

Highlights

• New breakthroughs in efficient, low-irritation functional skincare formulation
• Biomimetic lipids advancing barrier repair for sensitive skin
• Scientific skincare driving precise anti-aging solutions
• Antioxidant ingredients enabling effective whitening and anti-aging solutions
• Innovative applications of plant-based ingredients under natural, healthy, and environmentally friendly concepts

Agenda:

10:00 - 10:05 Opening remarks
10:05 - 10:10 CPHI Leadership address          
10:10 - 10:40 Society Report & JDSCT: Introduction to the International journal of skin science and cosmetic technology
10:40 - 11:10 Skin science-driven development of cosmetic ingredients
11:10 - 11:40 Clinical validation strategies for cosmetic safety & efficacy
11:40 - 12:10 TBD
12:10 - 13:30 Lunch break
13:30 - 14:00 Innovative efficacy assessment technologies for product differentiation
14:00 - 14:30 Herbal Wisdom Meets Tech Decoding: Medical-Cosmetic Translation in Efficacy Skincare
14:30 - 15:00 Functional  cosmetics: raw material breakthroughs, formulation innovations, and global market trends
15:00 - 15:30 TBD
15:30 - 15:45 Inauguration ceremony of the Cosmetics Professional Committee of the China Pharmaceutical University Guangdong - Hong Kong - Macau Alumni Association
15:45 - 16:00 Award presentation ceremony          
16:00 - 16:10 Conference closing summary

Agenda:

10:00 - 10:05 Opening remarks
10:05 - 10:10 Welcome speech
10:10 - 10:40 Planning, design and implementation strategies for smart pharmaceutical factories
10:40 - 11:10 Technological trends and regulatory logic of smart pharmaceutical manufacturing
11:10 - 11:40 New ecology of R&D in Chinese pharmaceutical enterprises: insights and solutions
11:40 - 12:30 Offline activity for industrial pharmaceutical formulation enthusiasts
13:00 - 13:25 The road to industrialization of new pharmaceutical formulations
13:25 - 13:55 TBD
13:55 - 14:25 TBD
14:25 - 14:55 TBD
14:55 - 15:20 Application of innovative low-temperature spray technology in the pharmaceutical industry
15:20 - 15:40 Development of new antibiotics driven by artificial intelligence for combating drug - resistant pathogens
15:40 - 16:00 Introduction to the cLNA oligonucleotide technology platform
16:00 - 16:20 Is the modernisation of traditional Chinese medicine a false proposition?

Agenda:

13:30 - 13:50 Analysis of the application prospects and successful case sharing of micro - needle transdermal formulations
13:50 - 14:20 The path to success of Chinese-style innovative drugs
14:20 - 14:40 Research, development, and industrialisation of high-end complex injection formulations
14:40 - 15:00 Commercial value, development strategies, and implementation pathways of sustained release new drugs
15:00 - 15:20 Full chain CDMO deep synergy: dual empowerment of technology transfer and process deepening
15:20 - 15:50 TBD
15:50 - 16:10 TBD

NEW: This session features AI English translation

Agenda:

10:00 - 10:02 Opening remarks
10:02 - 10:05 Opening remarks by the leader of Shenzhen Pharmaceutical and Medical Device Industry Outbound Alliance
10:05 - 10:25 Global restructuring of the biopharmaceutical market10:25 - 10:45 The internationalisation path of Indian pharmaceutical 
enterprises
10:45 - 11:05 MENA - a new blue ocean for Chinese pharmaceutical enterprises
11:05 - 11:25 Exploring opportunities and choices in South America pharmaceutical markets
11:25 - 12:15 Panel discussion: practical experience in emerging markets and innovative opportunities brought by new productivity

NEW: This session features AI English translation

Agenda:

13:30 - 14:10 Discussion on the reconstruction of pharmaceutical packaging material quality system, production compliance, and risk control under new regulations
14:10 - 14:50 Interpretation of pharmaceutical packaging material standards in the 2025 edition of Chinese Pharmacopoeia
14:50 - 15:30 Selection strategies for drug delivery devices in complex formulations
15:30 - 16:10 Case sharing: challenges and coping strategies for packaging materials and drug delivery devices in the process of Chinese pharmaceutical internationalisation

NEW: This session features AI English translation

Highlights

• How can DTP business stakeholders ensure compliance under stricter medical insurance supervision?
• Exploration and practice of internet healthcare platforms facilitating DTP prescription circulation
• New opportunities in the pharmaceutical market: jointly creating a blue ocean in the out-of-hospital market
• The surge in prescription circulation: new development opportunities for clinical agents/representatives
• How national negotiation, medical insurance, and self-pay products can expand in the out-of-hospital prescription circulation market?

Agenda:

09:30 - 10:00 Compliance strategies for DTP stakeholders amid stricter regulations
10:00 - 10:30 Digital healthcare platforms: innovations in DTP prescription circulation
10:30 - 11:00 New opportunities in the pharmaceutical market: creating new strategies for the Out-of-Hospital market
11:00 - 11:30 New opportunities for clinical agents/representatives in prescription circulation
11:30 - 12:00 Expanding out-of-hospital prescription markets for nationally negotiated, insurance-covered, and self-pay products

NEW: This session features AI English translation

Highlights:

• Consumer willingness-to-pay thresholds: how to transform scientific value into commercial value?
• The cost-efficiency paradox in flexible manufacturing beyond mass personalization: scaling truly individualized production
• Doctors, nutritionists, AI: who will dominate the final decision-making power for personalized nutrition?
• Consumer cognition and trust: how to break the stereotype that "precision nutrition =  gimmick"?

Agenda:

13:00 - 13:30 Women's whole-life health management: from genetic screening to precision nutrition solutions 
13:30 - 14:00 Insights into the challenges and breakthroughs of precision nutrition supplements from the industrial chain perspective
14:00 - 14:30 Precision nutrition in functional baking: market implementation lessons from ligao foods wholesome bakery workshop
14:30 - 15:00 Health effects of plant proteins and innovative applications of high-protein full-nutrition foods
15:00 - 16:00 Panel discussion: Breaking barriers in precision nutrition commercialisation

Agenda:

9:30 - 9:35 Opening remarks
9:35 - 10:05 Regulatory oversight of aesthetic medical devices
10:05 - 10:35 The journey and outlook of the pioneer in type A recombinant humanized collagen protein's global expansion
10:35 - 11:05 Next-Gen aesthetic R&D: engineering unparalleled product differentiation
11:05 - 11:35 Regenerative medicine-driven R&D: Asian beauty innovation from concept to commercialization
11:35 - 12:05 Navigating injectable aesthetics approval: regulatory strategy & review priorities

Process Innovation and Quality Control Session

14:00 - 14:30 What pain points can silk fibroin address in the aesthetic medicine field?
14:30 - 15:00 Profhilo five-point facelift
15:00 - 15:30 Injection material requirements for different clinical indications in aesthetic treatments (TBD)
15:30 - 16:00 The evolution of recombinant collagen: bio-self-crosslinking Gels
16:00 - 16:30 Novel materials for beauty anti-aging & regenerative repair: Based on recombinant human elastin and fusion matrix proteins

Synthetic Biology and Regenerative Materials Session

10:00 - 10:30 The innovative development of injection aesthetic medicine --- regenerative aesthetic medicine
10:30 - 11:00 AI-driven recombinant collagen design: accelerating development and application of anti-aging biomaterials
11:00 - 11:30 The application of biomedical new materials in aesthetic medicine (TBD)
11:30 - 12:00 Medical principles of regenerative materials and injection techniques

Highlights:

The conference will deeply focus on three core dimensions: policy and regulations, production technology, and quality control, while integrating pharmaceutical industry development trends in the Greater Bay Area through three thematic sub-forums. Simultaneously, the meeting will invite regulatory experts, corporate executives, and technical pioneers to gather together, creating the pharmaceutical industry's first intelligent exchange platform that connects the entire chain of research and development, production, and quality control.

Session One: Implementation of the 2025 Edition of the Chinese Pharmacopoeia

Date: 2 September / Location:  Forum Area B, Booth: 8C80

09:30 - 10:00 Interpretation and implementation strategies of changes in aseptic standards related to the 25th edition of the Pharmacopoeia
10:00 - 10:30 Inspection and control of new aseptic microorganisms added in the 25th edition of the Pharmacopoeia
10:30 - 11:00 How to meet the requirements of the new Pharmacopoeia and GMP for production equipment?
11:00 - 11:30 How to ensure the integrity of aseptic environmental monitoring data under new regulations?

Session Two: Empowering Pharmaceutical Quality Control with Laboratory Scientific Instruments

Date: 2 September / Location:  Forum Area B, Booth: 8C80

13:30 - 14:00 How can laboratory scientific instruments efficiently empower key quality control links in pharmaceutical production?
14:00 - 14:30 Nanocarrier-promoted tumor treatment: quality control of targeted delivery and controlled release
14:30 - 15:00 Strengthening laboratory safety management to build a lifeline for pharmaceutical quality
15:00 - 15:30 Practical tools for quality control in pharmaceutical
15:30 - 16:00 Panel discussion

Session Three: Analysis and Application Practice of Hot Topics in International Pharmaceutical Production Supervision Policies

Date: 3 September / Location:  Forum Area B, Booth: 8C80

10:00 - 10:40 Requirements for the maintenance and entry into the globalization path of drugs and quality system management
10:40 - 11:20 Key points of formulation and management of pharmaceutical production pollution control strategy
11:20 - 12:00 Sharing of key points of environmental monitoring in pharmaceutical production clean areas

Agenda:

9:20 - 9:30 Opening remark
9:30 - 10:10 Asian pharmaceutical market - regional exploration and decomposition
10:10 - 10:40 Analysis of the Malaysian pharmaceutical market and cooperation opportunities
10:40 - 11:10 Indian pharmaceutical market: potential impacts of tightening policies
11:10 - 11:40 Practice in exploring the Vietnamese pharmaceutical market
11:40 - 12:00 Access policies for Chinese health products in the Indonesian market
12:00 - 12:15 Panel discussion: exploration of "Variables in the Asian market and sustainable strategies"

Agenda:

9:30 - 9:35 Host opening
9:35 - 9:40 Opening remarks
9:40 - 10:00 Strategic development of functional food products
10:00 - 10:20 Omega-3 in chronic disease management: current status and prospects Omega-3
10:20 - 10:40 Research and development of gut health and probiotics
10:40 - 11:00 Precision nutrition for healthy aging in the big data era
11:00 - 11:30 Interactive discussion